Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system

被引:262
|
作者
Huang, Gangliang [1 ]
Huang, Hualiang [2 ]
机构
[1] Chongqing Normal Univ, Act Carbohydrate Res Inst, Chongqing 401331, Peoples R China
[2] Wuhan Inst Technol, Sch Chem & Environm Engn, Wuhan 430073, Hubei, Peoples R China
关键词
Hyaluronic acid; Carrier; Sustained release; Biopharmaceutical delivery; Tumor-targeted drug delivery; RELEASE FORMULATION; PACLITAXEL DELIVERY; SUSTAINED-RELEASE; NANOPARTICLES; SIRNA; CONJUGATE; LIPOSOMES; LUNG; DERIVATIVES; RESISTANCE;
D O I
10.1016/j.jconrel.2018.04.015
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Hyaluronic acid (HA) is a natural polysaccharide with good biocompatibility and degradability. HA and its derivatives can be used as sustained-release carriers for drugs, which can delay the release of drugs and have a long-acting effect. They can be used for the delivery of various drugs such as proteins, nucleic acids and antitumor drugs. HA and its derivatives can specifically bind to multiple receptors on the cell surface and can be used for targeted drug delivery, especially for the delivery of anti-tumor drugs. Thus, there are different forms of tumor-targeted drug delivery systems based on HA.
引用
收藏
页码:122 / 126
页数:5
相关论文
共 50 条
  • [41] Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery
    Thambi, Thavasyappan
    Deepagan, V. G.
    Yoon, Hong Yeol
    Han, Hwa Seung
    Kim, Seol-Hee
    Son, Soyoung
    Jo, Dong-Gyu
    Ahn, Cheol-Hee
    Suh, Yung Doug
    Kim, Kwangmeyung
    Kwon, Ick Chan
    Lee, Doo Sung
    Park, Jae Hyung
    BIOMATERIALS, 2014, 35 (05) : 1735 - 1743
  • [42] The Evolution of Tumor-Targeted Drug Delivery: From the EPR Effect to Nanoswimmers
    Zoabi, Nour
    Golani-Armon, Adi
    Zinger, Assaf
    Reshef, Maayan
    Yaari, Zvi
    Vardi-Oknin, Dikla
    Shatsberg, Zohar
    Shomar, Aseel
    Shainsky-Roitman, Janna
    Schroeder, Avi
    ISRAEL JOURNAL OF CHEMISTRY, 2013, 53 (9-10) : 719 - 727
  • [43] In vitro Preparation and Evaluation of Alendronate-modified Hyaluronic acid-based Nanomicelles as a Bone-Targeted Drug delivery system
    Alaei, Mahrokh Sadat
    Ganji, Fariba
    Shaki, Hossein
    JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY, 2024, 101
  • [44] Nanostructured hyaluronic acid-based materials for active delivery to cancer
    Ossipov, Dmitri A.
    EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (06) : 681 - 703
  • [45] Engineered Hyaluronic Acid-Based Smart Nanoconjugates for Enhanced Intracellular Drug Delivery
    Arjama, Mukherjee
    Mehnath, Sivaraj
    Rajan, Mariappan
    Jeyaraj, Murugaraj
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2023, 112 (06) : 1603 - 1614
  • [46] Facile preparation of hyaluronic acid-based quercetin nanoformulation for targeted tumor therapy
    Xiong, Qi
    Wang, Yiwu
    Wan, Jingyuan
    Yuan, Pei
    Chen, Huali
    Zhang, Liangke
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2020, 147 (147) : 937 - 945
  • [47] Recent studies on modulating hyaluronic acid-based hydrogels for controlled drug delivery
    Min-Hwan Kim
    Duy-Thuc Nguyen
    Dae-Duk Kim
    Journal of Pharmaceutical Investigation, 2022, 52 : 397 - 413
  • [48] Folate-conjugated nanodiamond for tumor-targeted drug delivery
    Dong, Yu
    Cao, Ruixia
    Li, Yingqi
    Wang, Zhiqin
    Li, Lin
    Tian, Lu
    RSC ADVANCES, 2015, 5 (101): : 82711 - 82716
  • [49] Drug-internalized bacterial swimmers for magnetically manipulable tumor-targeted drug delivery
    Xiang, Zhichu
    Jiang, Gexuan
    Fan, Di
    Tian, Jiesheng
    Hu, Zhiyuan
    Fang, Qiaojun
    NANOSCALE, 2020, 12 (25) : 13513 - 13522
  • [50] A simple but efficient tumor-targeted nanoparticle delivery system constructed by oleic acid
    Fu, Jingxin
    Wang, Yian
    Li, Haowen
    Lu, Likang
    Han, Meihua
    Guo, Yifei
    Wang, Xiangtao
    DRUG DELIVERY, 2022, 29 (01) : 2539 - 2548